Solid Biosciences (SLDB) Non-Current Assets (2017 - 2026)

Solid Biosciences (SLDB) has 10 years of Non-Current Assets data on file, last reported at $26.1 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 14.4% year-over-year to $26.1 million; the trailing twelve-month figure through Mar 2026 stood at $26.1 million (down 14.4% YoY), and the FY2025 full-year result was $27.1 million, down 13.64% from the prior year.
• Non-Current Assets declined to $26.1 million in Q1 2026, from $27.1 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $40.6 million in Q4 2022 to a low of $8.9 million in Q1 2022.
• A 5-year average of $32.1 million and a median of $33.4 million in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets retreated 18.54% in 2022 and surged 335.67% in 2023, its largest moves.
• Tracing SLDB's Non-Current Assets over 5 years: stood at $40.6 million in 2022, then decreased by 13.32% to $35.2 million in 2023, then retreated by 10.92% to $31.4 million in 2024, then fell by 13.64% to $27.1 million in 2025, then slipped by 3.61% to $26.1 million in 2026.
• Business Quant data shows SLDB's Non-Current Assets at $26.1 million in Q1 2026, $27.1 million in Q4 2025, and $29.1 million in Q3 2025.